Filing search / Cidara Therapeutics, Inc. / "Assessment" / Page 2

8-K

EX-99.2

ayfx4lwsi c7erfzc9

14 Dec 21

Regulation FD Disclosure

7:05am

8-K

EX-1.1

xxloj9m769sc2 wm6

8 Oct 21

Cidara Therapeutics Announces Pricing of Concurrent Public Offerings of Common Stock and Preferred Stock

5:19pm

8-K

EX-1.2

hwfi558vl uie

8 Oct 21

Cidara Therapeutics Announces Pricing of Concurrent Public Offerings of Common Stock and Preferred Stock

5:19pm

424B5

s8wdea xkz

8 Oct 21

Prospectus supplement for primary offering

5:17pm

424B5

91cz6k1mvqrf

8 Oct 21

Prospectus supplement for primary offering

5:15pm

424B5

mscqtq4l

7 Oct 21

Prospectus supplement for primary offering

4:07pm

424B5

x790e1eivaf5h47m

7 Oct 21

Prospectus supplement for primary offering

4:04pm